Glycoprotein IIb/IIIa receptor antagonists and risk of bleeding: a single-center experience in 1020 patients.
Ali A, Hashem M, Rosman HS, Moser L, Rehan A, Davis T, Romanelli M, LaLonde T, Yamasaki H, Barbish B, Michael J, Ali SA, Schreiber TL, Gardin JM.
Ali A, et al. Among authors: romanelli m.
J Clin Pharmacol. 2004 Nov;44(11):1328-32. doi: 10.1177/0091270004269559.
J Clin Pharmacol. 2004.
PMID: 15496651